Trial intelligence / Profile preview

HBOT for Ischemic Diabetic Foot Ulcers (DIONYSIUS)

NCT05804097Phase 4Active, not recruiting

Sponsor
University of Amsterdam
Start
Oct 2021
Primary completion
May 2025
Modality
NPI (Non-Pharmacological Intervention)
Countries
1
01

Overview

A Phase 4 trial of hyperbaric oxygen therapy in diabetic foot ulcer (DFU), peripheral vascular disease (PVD), sponsored by University of Amsterdam. Started Oct 2021; status: active, not recruiting.

02

Drugs

hyperbaric oxygen therapy
03

Conditions

diabetic foot ulcer (DFU)peripheral vascular disease (PVD)

Beyond the preview

Go deeper on NCT05804097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05804097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call